Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group

2015 ◽  
Vol 49 (1) ◽  
pp. 65-75 ◽  
Author(s):  
A. Lawrence Gould ◽  
Theodore C. Lystig ◽  
Yun Lu ◽  
Haoda Fu ◽  
Haijun Ma
2014 ◽  
Vol 37 (1) ◽  
pp. 94-104 ◽  
Author(s):  
Vaishali K. Patadia ◽  
Martijn J. Schuemie ◽  
Preciosa Coloma ◽  
Ron Herings ◽  
Johan van der Lei ◽  
...  

Vaccines ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. 242
Author(s):  
Hyesung Lee ◽  
Ju Hwan Kim ◽  
Young June Choe ◽  
Ju-Young Shin

Introduction: Diverse algorithms for signal detection exist. However, inconsistent results are often encountered among the algorithms due to different levels of specificity used in defining the adverse events (AEs) and signal threshold. We aimed to explore potential safety signals for two pneumococcal vaccines in a spontaneous reporting database and compare the results and performances among the algorithms. Methods: Safety surveillance was conducted using the Korea national spontaneous reporting database from 1988 to 2017. Safety signals for pneumococcal vaccine and its subtypes were detected using the following the algorithms: disproportionality methods comprising of proportional reporting ratio (PRR), reporting odds ratio (ROR), and information component (IC); empirical Bayes geometric mean (EBGM); and tree-based scan statistics (TSS). Moreover, the performances of these algorithms were measured by comparing detected signals with the known AEs or pneumococcal vaccines (reference standard). Results: Among 10,380 vaccine-related AEs, 1135 reports and 101 AE terms were reported following pneumococcal vaccine. IC generated the most safety signals for pneumococcal vaccine (40/101), followed by PRR and ROR (19/101 each), TSS (15/101), and EBGM (1/101). Similar results were observed for its subtypes. Cellulitis was the only AE detected by all algorithms for pneumococcal vaccine. TSS showed the best balance in the performance: the highest in accuracy, negative predictive value, and area under the curve (70.3%, 67.4%, and 64.2%). Conclusion: Discrepancy in the number of detected signals was observed between algorithms. EBGM and TSS calibrated noise better than disproportionality methods, and TSS showed balanced performance. Nonetheless, these results should be interpreted with caution due to a lack of a gold standard for signal detection.


2017 ◽  
Vol 26 (01) ◽  
pp. 291-305
Author(s):  
Alfred Sorbello ◽  
Anna Ripple ◽  
Joseph Tonning ◽  
Monica Munoz ◽  
Rashedul Hasan ◽  
...  

Summary Objectives: We seek to develop a prototype software analytical tool to augment FDA regulatory reviewers’ capacity to harness scientific literature reports in PubMed/MEDLINE for pharmacovigilance and adverse drug event (ADE) safety signal detection. We also aim to gather feedback through usability testing to assess design, performance, and user satisfaction with the tool. Methods: A prototype, open source, web-based, software analytical tool generated statistical disproportionality data mining signal scores and dynamic visual analytics for ADE safety signal detection and management. We leveraged Medical Subject Heading (MeSH) indexing terms assigned to published citations in PubMed/MEDLINE to generate candidate drug-adverse event pairs for quantitative data mining. Six FDA regulatory reviewers participated in usability testing by employing the tool as part of their ongoing real-life pharmacovigilance activities to provide subjective feedback on its practical impact, added value, and fitness for use. Results: All usability test participants cited the tool’s ease of learning, ease of use, and generation of quantitative ADE safety signals, some of which corresponded to known established adverse drug reactions. Potential concerns included the comparability of the tool’s automated literature search relative to a manual ‘all fields’ PubMed search, missing drugs and adverse event terms, interpretation of signal scores, and integration with existing computer-based analytical tools. Conclusions: Usability testing demonstrated that this novel tool can automate the detection of ADE safety signals from published literature reports. Various mitigation strategies are described to foster improvements in design, productivity, and end user satisfaction.


Drug Safety ◽  
2013 ◽  
Vol 36 (7) ◽  
pp. 565-572 ◽  
Author(s):  
Francesco Salvo ◽  
Florent Leborgne ◽  
Frantz Thiessard ◽  
Nicholas Moore ◽  
Bernard Bégaud ◽  
...  

2002 ◽  
Vol 11 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Eug�ne P. van Puijenbroek ◽  
Andrew Bate ◽  
Hubert G. M. Leufkens ◽  
Marie Lindquist ◽  
Roland Orre ◽  
...  

2018 ◽  
Vol 27 (11) ◽  
pp. 1249-1256 ◽  
Author(s):  
Caitlin Dodd ◽  
Alexandra Pacurariu ◽  
Osemeke U. Osokogu ◽  
Daniel Weibel ◽  
Carmen Ferrajolo ◽  
...  

Author(s):  
Ramin B. Arani ◽  
Antoni F.Z. Wisniewski

Drug development is a complex set of inter-linked processes in which the cumulative understanding of a drug's safety and efficacy profile is shaped during different learning phases. Often, drugs are approved based on limited safety information, for example in highly at risk or rare disease populations. Therefore, post approval, regulatory organizations have mandated proactive surveillance strategies that include the collection of reported adverse events experienced by exposed populations, some of whom may have been on treatment for extended periods of time. Analyzing these accumulating adverse event reports to understand their clinical significance, given the limitations imposed by the methods of data collection, is a complicated task. The aim of this chapter is to provide the readers with a general understanding of safety signal detection and assessment, followed by a description of statistical methods (both classical and Bayesian) typically utilized for quantifying the strength of association between a drug and an adverse event.


Sign in / Sign up

Export Citation Format

Share Document